This has a good advantage in that they have already expanded, and have 7000 kg per year capacity of dried bud, whereas others are planning that. They can go from sales level of about a tenth of that, to a higher level very quickly. Pesticides and contaminants are a big issue, and this company has pharmaceutical grade manufacturing at their Saskatoon facility of 97,000 ft.². They also have a facility in Michigan. They’ve been doing this for a long time. He likes medical more than recreational. He would wait for a lower price.


Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals

This has been focused strictly on the medical market, and not the recreational market. The stock is below where it was issued last December, probably because they have not talked about a recreational strategy.

Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

CanniMed Therapeutics(CMED-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for CanniMed Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CanniMed Therapeutics(CMED-T) Frequently Asked Questions

What is CanniMed Therapeutics stock symbol?

CanniMed Therapeutics is a Canadian stock, trading under the symbol CMED-T on the Toronto Stock Exchange (CMED-CT). It is usually referred to as TSX:CMED or CMED-T

Is CanniMed Therapeutics a buy or a sell?

In the last year, there was no coverage of CanniMed Therapeutics published on Stockchase.

Is CanniMed Therapeutics a good investment or a top pick?

CanniMed Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for CanniMed Therapeutics.

Why is CanniMed Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CanniMed Therapeutics worth watching?

In the last year, there was no coverage of CanniMed Therapeutics published on Stockchase.

What is CanniMed Therapeutics stock price?

On , CanniMed Therapeutics (CMED-T) stock closed at a price of $.